Inogen (INGN) on Tuesday reported adjusted income of 65 cents per share on sales of $97.2 million for its second quarter. In the year-earlier period, it reported adjusted earnings of 38 cents per share on $64.1 million in sales.
XAnalysts polled by Zacks Investment Research had called for adjusted profit of 44 cents per share on $82 million in sales.
For the year, Inogen guided to $340 million to $350 million in sales. Analysts had forecast adjusted earnings of $1.77 per share and $322 million in sales.
In after-hours trading on the stock market today, Inogen stock jumped 1.7% after closing down 0.2%, at 213.26. Inogen has a best-possible Composite Rating of 99. Six of 118 stocks in Investor's Business Daily's Medical-Products industry group have ratings of 99. The group itself is ranked third out of 197 industry groups tracked.
More to follow.
YOU MAY ALSO LIKE:
Can You Make Roaring Stock Profits With A Little Cash? Yes, Here Is The Way
How To Invest In Stocks For Free: New Apps Aim For Beginners
Looking For The Next Nvidia? Start With This Simple Routine
The post This Top-Rated Medtech Just Crushed Second-Quarter Views appeared first on Investor's Business Daily.
http://feedproxy.google.com/~r/BusinessRss/~3/HjHOEZNisP4/
No comments:
Post a Comment